115 related articles for article (PubMed ID: 9255000)
1. Assessment of chlorpromazine as radiation sensitizer and protector.
Huilgol NG; Chatterjee N; Singh BB
Indian J Cancer; 1996 Dec; 33(4):195-200. PubMed ID: 9255000
[TBL] [Abstract][Full Text] [Related]
2. A clinical study to assess chlorpromazine as hypoxic cell sensitizer in head & neck cancer treated with conventional radiation.
Huilgol NG; Chatterjee N; Singh BB
Indian J Cancer; 1998 Sep; 35(3):97-100. PubMed ID: 10226398
[TBL] [Abstract][Full Text] [Related]
3. Sanazole as a sensitizer of hypoxic cells with radical radiation in the treatment of advanced cancer of cervix an Indian experience.
Huilgol NG; Dobrowsky W; Tatsuzaki H; Chatterjee NA; Kagiya VT; Das K
Indian J Cancer; 2002 Jun; 39(2):39-44. PubMed ID: 12789723
[TBL] [Abstract][Full Text] [Related]
4. Results of a phase II trial of concurrent chemoradiation in the treatment of locally advanced carcinoma of uterine cervix: an experience from India.
Saibishkumar EP; Patel FD; Sharma SC
Bull Cancer; 2005 Jan; 92(1):E7-12. PubMed ID: 15811845
[TBL] [Abstract][Full Text] [Related]
5. AK-2123 (Sanazol) as a radiation sensitizer in the treatment of stage III cervical cancer: results of an IAEA multicentre randomised trial.
Dobrowsky W; Huigol NG; Jayatilake RS; Kizilbash NI; Okkan S; Kagiya VT; Tatsuzaki H
Radiother Oncol; 2007 Jan; 82(1):24-9. PubMed ID: 17161478
[TBL] [Abstract][Full Text] [Related]
6. A phase III randomized study of misonidazole plus radiation vs. radiation alone for cervix cancer.
Chan P; Milosevic M; Fyles A; Carson J; Pintilie M; Rauth M; Thomas G
Radiother Oncol; 2004 Mar; 70(3):295-9. PubMed ID: 15064016
[TBL] [Abstract][Full Text] [Related]
7. Concomitant chemobrachyradiotherapy with ifosfamide and cisplatin followed by consolidation chemotherapy in locally advanced squamous cell carcinoma of the uterine cervix: results of a phase II study.
Vrdoljak E; Prskalo T; Omrcen T; Situm K; Boraska T; Frleta Ilić N; Janković S; Hamm W
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):824-9. PubMed ID: 15708262
[TBL] [Abstract][Full Text] [Related]
8. Effect of concurrent intra-arterial infusion of platinum drugs for patients with stage III or IV uterine cervical cancer treated with radical radiation therapy.
Onishi H; Yamaguchi M; Kuriyama K; Tsukamoto T; Ishigame K; Ichikawa T; Aoki S; Yoshikawa T; Araki T; Nambu A; Araki T; Hashi A; Yasumizu T; Hoshi K; Ito H
Cancer J Sci Am; 2000; 6(1):40-5. PubMed ID: 10696738
[TBL] [Abstract][Full Text] [Related]
9. A retrospective review of 15 years of radical radiotherapy with or without concurrent cisplatin and/or 5-fluorouracil for the treatment of locally advanced cervical cancer.
Borowsky ME; Elliott KS; Pezzullo JC; Santoso P; Choi W; Choi K; Abulafia O
Bull Cancer; 2005 Feb; 92(2):E19-24. PubMed ID: 15749639
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous paclitaxel and radiotherapy: initial clinical experience in lung cancer and other malignancies.
Vogt HG; Martin T; Kolotas C; Schneider L; Strassmann G; Zamboglou N
Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-101-S12-105. PubMed ID: 9331131
[TBL] [Abstract][Full Text] [Related]
11. Phase I study of topotecan and radiation therapy in advanced cervical cancer.
Dunton CJ; King SA; Neufeld J; Tolosa J; Perez G; Avila A; Underhill K
Gynecol Oncol; 2002 Apr; 85(1):185-7. PubMed ID: 11925142
[TBL] [Abstract][Full Text] [Related]
12. Comparative evaluation of hypofractionated radiotherapy and conventional fractionated radiotherapy in the management of carcinoma of the cervix in Ibadan, Nigeria.
Campbell OB; Akinlade IB; Arowojolu A; Babarinsa IA; Agwimah RI; Adewole IF
Afr J Med Med Sci; 2000; 29(3-4):253-8. PubMed ID: 11714001
[TBL] [Abstract][Full Text] [Related]
13. Phase III double-blind randomized trial of radiation therapy for stage IIIb cervical cancer in combination with low- or high-dose Z-100: treatment with immunomodulator, more is not better.
Noda K; Ohashi Y; Sugimori H; Ozaki M; Niibe H; Ogita S; Kohno I; Hasegawa K; Kikuchi Y; Takegawa Y; Fujii S; Tanaka K; Ochiai K; Kita M; Fujiwara K
Gynecol Oncol; 2006 Jun; 101(3):455-63. PubMed ID: 16360199
[TBL] [Abstract][Full Text] [Related]
14. Measurement of serum squamous cell carcinoma antigen levels as a predictor of radiation response in patients with carcinoma of the uterine cervix.
Ohno T; Nakayama Y; Nakamoto S; Kato S; Imai R; Nonaka T; Ishikawa H; Harashima K; Suzuki Y
Cancer; 2003 Jun; 97(12):3114-20. PubMed ID: 12784349
[TBL] [Abstract][Full Text] [Related]
15. Completion hysterectomy after radiation therapy for bulky cervical cancer stages IB, IIA, and IIB: complications and survival rates.
Decker MA; Burke JJ; Gallup DG; Silverio RW; Weems D; Duttenhaver J; Purcell D
Am J Obstet Gynecol; 2004 Aug; 191(2):654-8; discussion 658-60. PubMed ID: 15343258
[TBL] [Abstract][Full Text] [Related]
16. High external parametrial dose can increase the probability of radiation proctitis in patients with uterine cervix cancer.
Huang EY; Lin H; Hsu HC; Wang CJ; Chen HC; Sun LM; Hsiung CY
Gynecol Oncol; 2000 Dec; 79(3):406-10. PubMed ID: 11104610
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia-induced treatment failure in advanced squamous cell carcinoma of the uterine cervix is primarily due to hypoxia-induced radiation resistance rather than hypoxia-induced metastasis.
Rofstad EK; Sundfør K; Lyng H; Tropé CG
Br J Cancer; 2000 Aug; 83(3):354-9. PubMed ID: 10917551
[TBL] [Abstract][Full Text] [Related]
18. Early determination of uterine cervical squamous cell carcinoma radioresponse identifies high- and low-response tumors.
Ohara K; Oki A; Tanaka YO; Onishi K; Fukumitsu N; Hashimoto T; Satoh T; Tsunoda H; Hata M; Sugahara S; Tokuuye K; Akine Y; Yoshikawa H
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1179-82. PubMed ID: 16343805
[TBL] [Abstract][Full Text] [Related]
19. Radiation therapy for elderly patient with squamous cell carcinoma of the uterine cervix.
Sakurai H; Mitsuhashi N; Takahashi M; Yamakawa M; Akimoto T; Hayakawa K; Niibe H
Gynecol Oncol; 2000 Apr; 77(1):116-20. PubMed ID: 10739700
[TBL] [Abstract][Full Text] [Related]
20. Radiation therapy of pelvic recurrence after radical hysterectomy for cervical carcinoma.
Ijaz T; Eifel PJ; Burke T; Oswald MJ
Gynecol Oncol; 1998 Aug; 70(2):241-6. PubMed ID: 9740698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
